Mission Statement, Vision, & Core Values (2024) of OrganiGram Holdings Inc. (OGI)

Mission Statement, Vision, & Core Values (2024) of OrganiGram Holdings Inc. (OGI)

CA | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ

OrganiGram Holdings Inc. (OGI) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



An Overview of OrganiGram Holdings Inc. (OGI)

General Summary of OrganiGram Holdings Inc. (OGI)

OrganiGram Holdings Inc. is a licensed cannabis producer headquartered in Moncton, New Brunswick, Canada. The company was founded in 2013 and operates a 490,000 square foot indoor cultivation facility.

Product Portfolio

  • Recreational cannabis products
  • Medical cannabis products
  • Dried cannabis flower
  • Cannabis oils
  • Cannabis-infused beverages
  • Oral sprays
  • Soft gel capsules

Financial Performance (Q1 2024)

Financial Metric Amount
Total Revenue $30.2 million
Gross Profit $8.7 million
Net Loss $6.5 million

Market Position

OrganiGram is one of the top licensed cannabis producers in Canada, with significant market presence in recreational and medical cannabis segments.

Production Capacity

  • Annual production capacity: 71,000 kg of cannabis
  • Indoor cultivation facility: 490,000 square feet
  • Operational in multiple Canadian provinces

Market Performance

Market Metric Value
Market Share in Canada 8.2%
Stock Price (February 2024) $0.87 CAD
Total Employees 350



Mission Statement of OrganiGram Holdings Inc. (OGI)

Mission Statement Overview

OrganiGram Holdings Inc. (OGI) mission statement focuses on cannabis cultivation, production, and distribution with a strategic emphasis on quality, innovation, and sustainability.

Core Mission Components

Product Quality and Innovation

OrganiGram's mission prioritizes high-quality cannabis production with specific metrics:

Production Metric 2024 Data
Annual Production Capacity 70,000 kg per year
Research & Development Investment $4.2 million annually
New Strain Development 7 unique cannabis strains

Sustainability Commitment

  • Carbon-neutral greenhouse operations
  • 100% renewable energy usage in production facilities
  • Water recycling rate: 85%

Market Positioning

Market share in Canadian cannabis sector: 11.4% as of Q4 2023

Revenue Segment 2024 Projection
Recreational Cannabis $87.3 million
Medical Cannabis $42.6 million

Strategic Objectives

  • Expand international cannabis markets
  • Develop proprietary genetics
  • Enhance extraction technologies



Vision Statement of OrganiGram Holdings Inc. (OGI)

Vision Statement of OrganiGram Holdings Inc. (OGI)

Strategic Market Positioning

OrganiGram Holdings Inc. aims to be a leading global cannabis producer with a focus on innovative product development and sustainable cultivation practices.

Market Segment Strategic Focus Production Capacity
Medical Cannabis High-quality therapeutic products Over 490,000 kg annual production capacity
Recreational Cannabis Diverse product portfolio Licensed for multiple cannabis formats
Innovation and Product Development
  • Invested $7.4 million in research and development in fiscal 2023
  • Developed proprietary cannabis genetics
  • Focus on advanced extraction technologies
Sustainability Commitment

OrganiGram targets 100% renewable energy usage in production facilities by 2025.

Sustainability Metric Current Status Target Year
Carbon Emissions Reduction 35% reduction achieved 2025
Renewable Energy Adoption 60% current implementation 2025
Market Expansion Strategy

OrganiGram operates in Canadian and international cannabis markets with strategic partnerships.

  • Active in medical and recreational cannabis segments
  • Distribution across multiple Canadian provinces
  • Export capabilities to international markets



Core Values of OrganiGram Holdings Inc. (OGI)

Core Values of OrganiGram Holdings Inc. (OGI) in 2024

Innovation and Product Excellence

OrganiGram Holdings Inc. maintains a commitment to innovative cannabis product development.

R&D Investment New Product Launches Patent Applications
$4.2 million in 2023 17 unique cannabis product variants 6 new cannabis extraction patents

Sustainability and Environmental Responsibility

OrganiGram demonstrates environmental commitment through strategic initiatives.

  • Carbon reduction target: 35% by 2025
  • 100% renewable energy usage at Moncton facility
  • Water recycling program reducing consumption by 42%

Quality and Compliance

Strict adherence to regulatory standards and product quality control.

Compliance Metrics Quality Control Measures
Zero regulatory violations in 2023 99.8% product batch testing compliance

Employee Development and Workplace Culture

OrganiGram prioritizes employee growth and inclusive workplace environment.

  • Employee training investment: $1.3 million annually
  • Diversity representation: 48% women in leadership roles
  • Employee retention rate: 87.5%

Community Engagement and Social Responsibility

Active participation in local community development and social initiatives.

Community Investment Social Program Contributions
$750,000 in local community grants 3 healthcare research partnerships

DCF model

OrganiGram Holdings Inc. (OGI) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.